Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 85.54M | 81.00M | 86.98M | 73.33M | 112.80M | 52.33M |
Gross Profit | 50.92M | 44.02M | 54.53M | 39.70M | 68.19M | 19.35M |
EBITDA | 44.75M | 48.38M | 53.84M | 31.94M | 64.67M | 8.73M |
Net Income | 26.27M | 22.22M | 27.50M | 10.76M | 38.22M | -26.74M |
Balance Sheet | ||||||
Total Assets | 85.34M | 333.57M | 318.28M | 326.40M | 349.76M | 334.79M |
Cash, Cash Equivalents and Short-Term Investments | 10.21M | 80.05M | 63.04M | 74.97M | 97.74M | 88.47M |
Total Debt | 0.00 | 1.45M | 1.75M | 13.91M | 4.16M | 7.64M |
Total Liabilities | 82.19M | 59.47M | 63.91M | 93.33M | 95.88M | 103.19M |
Stockholders Equity | 3.14M | 274.10M | 254.37M | 233.07M | 253.88M | 231.61M |
Cash Flow | ||||||
Free Cash Flow | 14.65M | 20.06M | 8.42M | 1.07M | 22.55M | 4.50M |
Operating Cash Flow | 20.20M | 30.82M | 12.54M | 1.16M | 30.14M | 9.23M |
Investing Cash Flow | -5.23M | -10.74M | -3.79M | -13.74M | 10.19M | -4.72M |
Financing Cash Flow | -11.43M | -2.10M | -19.68M | -5.84M | -33.37M | -9.41M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | $2.85B | 10.97 | 11.86% | ― | 10.53% | 26.74% | |
68 Neutral | HK$3.03B | 29.76 | 4.16% | 3.28% | 1.09% | ― | |
67 Neutral | HK$34.06B | 83.58 | 2.29% | ― | 31.62% | 3.08% | |
66 Neutral | ¥440.91B | 15.12 | 2.58% | 2.33% | 5.79% | -10.55% | |
46 Neutral | HK$139.98M | ― | -12.77% | ― | -8.19% | -498.76% | |
46 Neutral | HK$568.68M | ― | -20.32% | ― | 27.72% | -117.07% | |
43 Neutral | HK$1.32B | ― | ― | ― | ― |
IMAX China Holding, Inc. reported a substantial increase in its interim financial results for the first half of 2025, with revenues rising to $57.8 million from $43.9 million in the same period the previous year. The company’s operating profit nearly doubled to $30.2 million, reflecting strong performance and efficient cost management. The announcement highlights the company’s robust growth trajectory and its strategic positioning in the entertainment technology sector, which is likely to bolster stakeholder confidence.
IMAX China Holding, Inc. has announced a board meeting scheduled for July 24, 2025, to discuss and approve the interim results for the first half of the year ending June 30, 2025. The meeting will also consider the possibility of an interim dividend and address other business matters, indicating a review of the company’s financial performance and potential shareholder returns.
IMAX China Holding, Inc. announced the grant of 473,400 Restricted Share Units (RSUs) to five directors as part of their remuneration package. This grant represents approximately 0.14% of the company’s issued share capital and is valued at around HK$3,896,082. The RSUs, which are exempt from certain reporting and approval requirements, will vest immediately without performance conditions, and a professional trustee will manage the administration and vesting process.
IMAX China Holding, Inc. held its Annual General Meeting on June 12, 2025, where all proposed resolutions were passed. Key resolutions included the re-election of directors, authorization for directors to fix remuneration, reappointment of auditors, and mandates for share buybacks and issuance. These decisions reflect a strategic focus on maintaining strong governance and operational flexibility, potentially enhancing shareholder value.
IMAX China Holding, Inc. has announced its Annual General Meeting scheduled for June 12, 2025, in Shanghai, China. Key agenda items include the re-election of three non-executive directors, the re-appointment of PricewaterhouseCoopers as auditors, and the authorization for the company to buy back shares and issue additional shares. These resolutions aim to strengthen the company’s governance and provide flexibility in capital management, potentially impacting its market positioning and shareholder value.